Elevated levels of inflammatory markers such as IL-6, IL-17, and TNF-α are commonly observed in PCOS patients (16, 17) and are closely associated with follicular developmental arrest, insulin resistance, and metabolic syndrome (18). This evidence concerns the gene IL17A and metabolic syndrome.